169 related articles for article (PubMed ID: 2167183)
1. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Memoli VA; Longnecker DS
Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of streptozotocin on tumor development in transgenic mice bearing an elastase I-SV40 T-antigen fusion gene.
Bell RH; Brinck-Johnsen T; Longnecker DS
Pancreas; 1991 Jul; 6(4):475-8. PubMed ID: 1678889
[TBL] [Abstract][Full Text] [Related]
3. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
Povoski SP; Zhou W; Longnecker DS; Bell RH
Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
[TBL] [Abstract][Full Text] [Related]
5. Oncogenic co-operation in beta-cell tumorigenesis.
Pelengaris S; Khan M
Endocr Relat Cancer; 2001 Dec; 8(4):307-14. PubMed ID: 11733227
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.
Ornitz DM; Hammer RE; Messing A; Palmiter RD; Brinster RL
Science; 1987 Oct; 238(4824):188-93. PubMed ID: 2821617
[TBL] [Abstract][Full Text] [Related]
7. Development of colonic and pancreatic endocrine tumours in mice expressing a glucagon-SV40 T antigen transgene.
Asa SL; Lee YC; Drucker DJ
Virchows Arch; 1996 Mar; 427(6):595-606. PubMed ID: 8605571
[TBL] [Abstract][Full Text] [Related]
8. Neoplasia and hyperplasia of pancreatic endocrine tissue in the rat: an immunocytochemical study.
Spencer AJ; Andreu M; Greaves P
Vet Pathol; 1986 Jan; 23(1):11-5. PubMed ID: 3004001
[TBL] [Abstract][Full Text] [Related]
9. Cell lines derived from pancreatic tumors of Tg(Ela-1-SV40E)Bri18 transgenic mice express somatostatin and T antigen.
Pettengill OS; Memoli VA; Brinck-Johnsen T; Longnecker DS
Carcinogenesis; 1994 Jan; 15(1):61-5. PubMed ID: 7904904
[TBL] [Abstract][Full Text] [Related]
10. Endocrine pancreatic tumors in MSV-SV40 large T transgenic mice.
Götz W; Schucht C; Roth J; Theuring F; Herken R
Am J Pathol; 1993 May; 142(5):1493-503. PubMed ID: 8388173
[TBL] [Abstract][Full Text] [Related]
11. Transgene expression and repression in transgenic rats bearing the phosphoenolpyruvate carboxykinase-simian virus 40 T antigen or the phosphoenolpyruvate carboxykinase-transforming growth factor-alpha constructs.
Haas MJ; Dragan YP; Hikita H; Shimel R; Takimoto K; Heath S; Vaughan J; Pitot HC
Am J Pathol; 1999 Jul; 155(1):183-92. PubMed ID: 10393850
[TBL] [Abstract][Full Text] [Related]
12. Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice.
Ye X; McCarrick J; Jewett L; Knowles BB
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3916-20. PubMed ID: 8171012
[TBL] [Abstract][Full Text] [Related]
13. [Insulinomas in children. Histologic and ultrastructural study. (apropos of 2 cases)].
Casanova P; Guidon J; Laffargue P
Ann Anat Pathol (Paris); 1975; 20(5):489-503. PubMed ID: 182046
[TBL] [Abstract][Full Text] [Related]
14. Tissue specificity of L-pyruvate kinase transgenes results from the combinatorial effect of proximal promoter and distal activator regions.
Miquerol L; Cluzeaud F; Porteu A; Alexandre Y; Vandewalle A; Kahn A
Gene Expr; 1996; 5(6):315-30. PubMed ID: 8836739
[TBL] [Abstract][Full Text] [Related]
15. A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice.
Tevethia MJ; Bonneau RH; Griffith JW; Mylin L
J Virol; 1997 Nov; 71(11):8157-66. PubMed ID: 9343166
[TBL] [Abstract][Full Text] [Related]
16. Islet amyloid polypeptide in proliferating pancreatic B cells during development, hyperplasia, and neoplasia in humans and mice.
Rindi G; Terenghi G; Westermark G; Westermark P; Moscoso G; Polak JM
Am J Pathol; 1991 Jun; 138(6):1321-34. PubMed ID: 1647136
[TBL] [Abstract][Full Text] [Related]
17. Nesidioblastosis, islet cell hyperplasia, and adenomatosis in a case of metastasizing insulinoma: contribution to the genesis of the islets of Langerhans.
Leong AS; Slavotinek AH; Higgins BA
Diabetes Care; 1980; 3(4):537-42. PubMed ID: 6257459
[TBL] [Abstract][Full Text] [Related]
18. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice.
Teitz T; Yen TS; Chang JC; Kan YW
DNA Cell Biol; 1994 Jul; 13(7):705-10. PubMed ID: 7772251
[TBL] [Abstract][Full Text] [Related]
19. Nesidioblastosis and intermediate cells in the pancreas of patients with hyperinsulinemic hypoglycemia.
Bani D; Bani Sacchi T; Biliotti G
Virchows Arch B Cell Pathol Incl Mol Pathol; 1985; 48(1):19-32. PubMed ID: 2858937
[TBL] [Abstract][Full Text] [Related]
20. [Morphological and immunocytochemical studies of pancreatic multiple endocrine neoplasia type-1].
Yonemura U; Konishi K; Miazaki I; Miwa K
Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):811-9. PubMed ID: 6092890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
